Effects of a multisectoral household agricultural and livelihood intervention on nutrition, development, and morbidity among HIV-affected children 6 to 36 months of age in Western Kenya: A cluster-randomized trial
In brief
Agriculture and livelihood program added 1.2 cm in height for younger children
In a Kenyan cluster-randomized trial, children who were 6 to under 24 months at enrollment gained about 1.2 cm more height over two years with the household intervention than controls, but weight gain and developmental outcomes did not differ. Cough was less common in younger children and diarrhea less common in older children; benefits were not seen across all ages or outcomes.
- Journal
- The American journal of clinical nutrition (Q1)
- Published
- 16 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Lisa M Butler, Phelgona Otieno, Bezawit E Kase, Kathleen M Powis, Betsy Kammerer, Elly Weke, et al.
- PMID
- 43039145
- DOI
- 10.1016/j.ajcnut.2026.101632
Why clinicians should know about it
- Picked for Pediatrics and Child Health (paper of the day, 18 November 2026): Randomized trial informs child growth, development, and morbidity
Abstract
BACKGROUND: Food insecurity and HIV are interconnected, potentially increasing nutritional and health-related risks. OBJECTIVE: The Pediatric Shamba Maisha study evaluated the effects of an agricultural and livelihood intervention on growth, development, and common morbidities among children in HIV-affected households in Kenya. METHODS: The Pediatric Shamba Maisha study was a parallel-arm cluster-randomised controlled trial nested within a multisectoral agriculture and livelihood intervention trial among food-insecure adults living with HIV in rural Kenya. The Pediatric Study enrolled children aged 6 to 36 months from participating households. Anthropometric and clinical data were collected every 6 months for 24 months. RESULTS: Of the 359 children enrolled (intervention arm=173, control arm=186), 334 (90%) completed the 24-month visit. In 215 children aged 6 to <24 months at enrolment, height/length increased more in the intervention arm than in the control arm (βheight: 1.18 cm, p=0.004, 95% confidence interval (CI) = (0.390,1.98); βheight-for-age z-score: 0.390, p=0.007, 95% CI = (0.109,0.670)). Weight change of children enrolled at aged 6 to <24 months was similar between study arms across 24 months (βweight: -0.126 kg, p=0.299, 95% CI = (-0.3647,0.113); βweight-for-age z-score: -0.099, p=0.279, 95% CI = (-0.278,0.080)). In 142 children aged 24 to 36 months at enrolment, changes in height and weight over time did not differ between arms. For the intervention compared to control, younger children had lower prevalence of cough (β: -0.790 log-odds, p = 0.037, 95% CI = (-1.57,-0.047)), and older children had lower prevalence of diarrhoea (β: -1.66 log-odds, p = 0.017, 95% CI = (-3.03,-0.296)). Neurobehavioral development outcomes did not differ between study arms. CONCLUSIONS: The intervention improved growth and health of children aged 6 to <24 months at enrolment, underscoring the importance of early-life interventions. TRIAL REGISTRATION: ClinicalTrials.gov Identifiers: NCT02815579, NCT03170986https://clinicaltrials.gov/study/NCT02815579?term=NCT02815579&rank=1https://clinicaltrials.gov/study/NCT03170986?term=NCT03170986&rank=1.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.